MicroRNA as a New Blood-Borne Novel Biomarker for the Earlier Diagnosis of Lung Cancer: OAJBS Publishers
MicroRNA as a New Blood-Borne Novel Biomarker for the Earlier Diagnosis of Lung Cancer by Muhammad Siraj* in Open Access Journal of Biomedical Science (OAJBS)
Throughout
the world, lung cancer is the first leading cause of cancer-related death,
estimating roundabout 1.6 million cancer deaths occur annually. Lung cancer
with its highest incident and deaths/mortality all over the world due to its
limited diagnosis and treatment strategies. The earlier diagnosis of lung
cancer plays an important in its treatment. There are different techniques used
for the diagnosis of lung cancer including sputum cytology, different
nanoparticles, and biomarkers such as CYFRA 21-1, NSE, SCC, CEA, ProGRP, Tumor
M2-PK, miRNA. The main objective of this study is the role of miRNA as a novel
biomarker for the earlier diagnosis of lung cancer. MicroRNAs are a very effective
diagnosis marker for the earlier detection of lung cancer with high specificity
and sensitivity about 96.6% and 86.2% respectively.
https://biomedscis.com/fulltext/microrna-as-a-new-blood-borne-novel-biomarker-for-the-earlier-diagnosis-of-lung-cancer.ID.000256.php
To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis
Are Click on: https://Biomedscis.Com/
Comments
Post a Comment